Clinical outcomes of intra-articular injection of cross-linked hyaluronic acid with mannitol in patients with primary knee osteoarthritis
Main Article Content
Abstract
A controlled interventional study was conducted on 72 patients diagnosed with primary knee osteoarthritis and managed at the Department of Rheumatology, Thai Nguyen National Hospital, from October 2024 to October 2025. Patients were allocated into two groups: a control group receiving standard pharmacologic therapy and an intervention group receiving the same regimen supplemented with intra-articular administration of cross-linked hyaluronic acid enriched with mannitol. Treatment efficacy was evaluated using changes in VAS pain scores, WOMAC indices, and ultrasonographic findings at 1-month and 6-month follow-ups. Results: At 6 months, the intervention group exhibited a statistically significant reduction in VAS scores (from 5.72 ± 0.15 to 1.39 ± 0.46; p < 0.05), accompanied by substantial improvements across WOMAC pain, stiffness, and physical function domains. Post-intervention ultrasonography revealed absence of joint effusion in 91.5% of patients, and the prevalence of synovitis decreased significantly compared with baseline (p < 0.05). Conclusion: Intra-articular injection of cross-linked hyaluronic acid combined with mannitol demonstrates favorable therapeutic efficacy and contributes to meaningful improvements in pain relief and functional outcomes in patients with primary knee osteoarthritis.
Article Details
Keywords
Primary knee osteoarthritis, hyaluronic acid, mannitol, intra-articular injection
References
2. CH E. Novel biological approaches to the intra-articular treatment of osteoarthritis. BioDrugs. 2005:355-362.
3. Nguyễn Thị Lý NTNL, Phạm Hoài Thu. Kết quả điều trị thoái hóa khớp gối nguyên phát bằng liệu pháp tiêm nội khớp acid hyaluronic kết hợp với Sorbitol. Tạp chí Y học Việt Nam. 12/2021;
4. Mendoza G, Alvarez AI, Pulido MM, et al. Inhibitory effects of different antioxidants on hyaluronan depolymerization. Carbohydrate research. Jan 15 2007;342(1):96-102. doi:10.1016/j.carres.2006.10.027
5. Bossert M, Boublil D, Parisaux JM, Bozgan AM, Richelme E, Conrozier T. Imaging Guidance Improves the Results of Viscosupplementation with HANOX-M-XL in Patients with Ankle Osteoarthritis: Results of a Clinical Survey in 50 Patients Treated in Daily Practice. Clinical medicine insights Arthritis and musculoskeletal disorders. 2016;9:195-199. doi:10.4137/cmamd.s40401
6. Solène Perruchet J-CBea. The Association between Radiographic Features and the Duration of Effectiveness of a Single Injection of Extended-Release Hyaluronic Acid (HANOX-M-XL) in Patients with Knee Osteoarthritis: Preliminary Results of a Prospective Trial 2021;
7. Altman RD. Criteria for classification of clinical osteoarthritis. The Journal of rheumatology Supplement. Feb 1991;27:10-2.
8. Matthieu Monet A-MBaTC. Safety and Efficacy of Single Intra-Articular Injection
of a Cross-Linked Hyaluronic Acid/Mannitol
Formulation [Happycross®] in knee Osteoarthritis
Results of a Prospective Observational
Study in Daily Practice Conditions. Juniper Publishers March 24, 2017;
9. Conrozier T, Eymard F, Afif N, Balblanc JC, Legré-Boyer V, Chevalier X. Safety and efficacy of intra-articular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis: Results of a double-blind, controlled, multicenter, randomized trial. The Knee. Oct 2016;23(5):842-8. doi:10.1016/j.knee.2016.05.015